Synthesis and biological evaluation of 2- and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization. 2007

Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Dora Carrion, and Carlota Lopez Cara, and Delia Preti, and Francesca Fruttarolo, and Maria Giovanna Pavani, and Mojgan Aghazadeh Tabrizi, and Manlio Tolomeo, and Stefania Grimaudo, and Antonella Di Cristina, and Jan Balzarini, and John A Hadfield, and Andrea Brancale, and Ernest Hamel
Dipartimento di Scienze Farmaceutiche, Università di Ferrara, 44100 Ferrara, Italy.

Two new series of inhibitors of tubulin polymerization based on the 2-amino-3-(3,4,5-trimethoxybenzoyl)benzo[b]thiophene molecular skeleton and its 3-amino positional isomer were synthesized and evaluated for antiproliferative activity, inhibition of tubulin polymerization, and cell cycle effects. Although many more 3-amino derivatives have been synthesized so far, the most promising compound in this series was 2-amino-6-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[b]thiophene, which inhibits cancer cell growth at subnanomolar concentrations and interacts strongly with tubulin by binding to the colchicine site.

UI MeSH Term Description Entries
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D003078 Colchicine A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (PERIODIC DISEASE). Colchicine, (+-)-Isomer,Colchicine, (R)-Isomer
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013876 Thiophenes A monocyclic heteroarene furan in which the oxygen atom is replaced by a sulfur. Thiophene

Related Publications

Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Dora Carrion, and Carlota Lopez Cara, and Delia Preti, and Francesca Fruttarolo, and Maria Giovanna Pavani, and Mojgan Aghazadeh Tabrizi, and Manlio Tolomeo, and Stefania Grimaudo, and Antonella Di Cristina, and Jan Balzarini, and John A Hadfield, and Andrea Brancale, and Ernest Hamel
August 2020, Bioorganic & medicinal chemistry letters,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Dora Carrion, and Carlota Lopez Cara, and Delia Preti, and Francesca Fruttarolo, and Maria Giovanna Pavani, and Mojgan Aghazadeh Tabrizi, and Manlio Tolomeo, and Stefania Grimaudo, and Antonella Di Cristina, and Jan Balzarini, and John A Hadfield, and Andrea Brancale, and Ernest Hamel
January 2023, Assay and drug development technologies,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Dora Carrion, and Carlota Lopez Cara, and Delia Preti, and Francesca Fruttarolo, and Maria Giovanna Pavani, and Mojgan Aghazadeh Tabrizi, and Manlio Tolomeo, and Stefania Grimaudo, and Antonella Di Cristina, and Jan Balzarini, and John A Hadfield, and Andrea Brancale, and Ernest Hamel
July 2021, Bioorganic chemistry,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Dora Carrion, and Carlota Lopez Cara, and Delia Preti, and Francesca Fruttarolo, and Maria Giovanna Pavani, and Mojgan Aghazadeh Tabrizi, and Manlio Tolomeo, and Stefania Grimaudo, and Antonella Di Cristina, and Jan Balzarini, and John A Hadfield, and Andrea Brancale, and Ernest Hamel
July 2021, Bioorganic chemistry,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Dora Carrion, and Carlota Lopez Cara, and Delia Preti, and Francesca Fruttarolo, and Maria Giovanna Pavani, and Mojgan Aghazadeh Tabrizi, and Manlio Tolomeo, and Stefania Grimaudo, and Antonella Di Cristina, and Jan Balzarini, and John A Hadfield, and Andrea Brancale, and Ernest Hamel
August 2020, European journal of medicinal chemistry,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Dora Carrion, and Carlota Lopez Cara, and Delia Preti, and Francesca Fruttarolo, and Maria Giovanna Pavani, and Mojgan Aghazadeh Tabrizi, and Manlio Tolomeo, and Stefania Grimaudo, and Antonella Di Cristina, and Jan Balzarini, and John A Hadfield, and Andrea Brancale, and Ernest Hamel
November 2020, Iranian journal of basic medical sciences,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Dora Carrion, and Carlota Lopez Cara, and Delia Preti, and Francesca Fruttarolo, and Maria Giovanna Pavani, and Mojgan Aghazadeh Tabrizi, and Manlio Tolomeo, and Stefania Grimaudo, and Antonella Di Cristina, and Jan Balzarini, and John A Hadfield, and Andrea Brancale, and Ernest Hamel
May 2018, RSC advances,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Dora Carrion, and Carlota Lopez Cara, and Delia Preti, and Francesca Fruttarolo, and Maria Giovanna Pavani, and Mojgan Aghazadeh Tabrizi, and Manlio Tolomeo, and Stefania Grimaudo, and Antonella Di Cristina, and Jan Balzarini, and John A Hadfield, and Andrea Brancale, and Ernest Hamel
January 2014, Bioorganic & medicinal chemistry,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Dora Carrion, and Carlota Lopez Cara, and Delia Preti, and Francesca Fruttarolo, and Maria Giovanna Pavani, and Mojgan Aghazadeh Tabrizi, and Manlio Tolomeo, and Stefania Grimaudo, and Antonella Di Cristina, and Jan Balzarini, and John A Hadfield, and Andrea Brancale, and Ernest Hamel
June 2012, Molecules (Basel, Switzerland),
Romeo Romagnoli, and Pier Giovanni Baraldi, and Maria Dora Carrion, and Carlota Lopez Cara, and Delia Preti, and Francesca Fruttarolo, and Maria Giovanna Pavani, and Mojgan Aghazadeh Tabrizi, and Manlio Tolomeo, and Stefania Grimaudo, and Antonella Di Cristina, and Jan Balzarini, and John A Hadfield, and Andrea Brancale, and Ernest Hamel
March 2017, ChemMedChem,
Copied contents to your clipboard!